Denial Management Services
Denied claims are a serious money problem for healthcare providers today because insurance rules are much stricter. At Revix MD, we manage billing denials to truly improve your finances, instead of just tracking our activities.
Denial Impact
The Financial Impact of Rising Denial Rates
According to MGMA and HFMA benchmarks, average denial rates across U.S. healthcare range between 5%-10%, while top-performing organizations maintain rates below 2%. Even small increases in denials can disrupt cash flow, extend Days in A/R and reduce net collections.
More importantly, the real risk is not the denial itself – it is the percentage of claims that are never recovered.
Denials are not random. They are operational signals tied to gaps in eligibility verification, authorization workflows, coding accuracy, documentation quality and payer policy alignment.
A denial management partner that cannot work these codes at scale will struggle to recover revenue effectively.
Common denial codes we manage daily (according to HIPAA standards) include:
Modifier inconsistency
Missing or incorrect information
Medical necessity denial
Bundling or included service
Non-covered charges
Our Approach
A Structured Approach to Claim Denial Management
Revix MD delivers insurance claim denial management through a unified framework that combines recovery, analysis and prevention.
We begin with denial identification using ERA and EOB data, categorizing denials by payer, CPT code, denial code and financial impact. This allows prioritization of high-value claims and faster recovery cycles.
Technical Denials (CO-4, CO-16)
Caused by front-end errors such as missing authorization, incorrect modifiers or invalid patient data. These are resolved through workflow correction.
Clinical Denials (CO-50)
Driven by medical necessity, level of care or documentation gaps. These require physician-supported appeals and payer policy alignment.
Most vendors treat these the same. Revix MD builds distinct workflows for each, which is why our appeal outcomes are consistently higher.
Recovery & Prevention
Denial Analysis, Recovery & Appeal Management
Our denial recovery process goes beyond resubmission. Each denied claim is evaluated for:
Appeal Management Services
Our appeal management services are structured and payer-specific. We develop detailed appeal narratives supported by clinical documentation, coding validation and policy references.
We track every submission, enforce follow-ups and escalate when required.
Average Appeal Overturn Rate: Up to 78% across high-value denial categories
This includes strong performance in:
- Medical necessity denial appeals
- Bundling and modifier disputes (CO-97, CO-4)
- Missing information corrections (CO-16)
Timely Filing Denial Recovery
Timely filing denials are among the most preventable and the most costly. Once payer deadlines pass, revenue is permanently lost.
Revix MD implements:
- Filing deadline tracking by payer
- Real-time claim status monitoring
- Escalation workflows before expiration
Our proactive approach to timely filing denial recovery protects revenue that many organizations unknowingly forfeit.
Root Cause Prevention
Sustainable results require more than recovery. Revix MD combines denial analytics with operational improvements to prevent recurrence. Our analysis spans:
- Front-end intake and eligibility verification
- Authorization controls
- Charge capture workflows
- Coding precision
- Documentation integrity
We also identify payer-specific denial patterns, allowing targeted corrections. For example:
- Orthopedic practices often face CO-97 unbundling denials
- Behavioral health providers frequently encounter CO-50 medical necessity denials
- Multi-specialty groups see high volumes of CO-16 documentation-related denials
This level of visibility transforms denial management from reactive correction into proactive control.
Specialty-Specific Patterns
This level of visibility transforms denial management from reactive correction into proactive control across your entire practice.
Transform Denials into Revenue Opportunity
Denied claims represent revenue already earned. When managed strategically, they become an opportunity to improve operations and stabilize cash flow.
Frequently Asked Questions
What is your appeal overturn rate for clinical denials?
Our overturn rate reaches up to 78% for high-value clinical denials, including medical necessity cases, depending on documentation quality and payer policy alignment.
How do you handle timely filing denials?
We track payer deadlines in real time, prioritize at-risk claims and escalate before filing windows close to prevent permanent revenue loss.
What is the difference between a CO-16 and CO-50 denial?
CO-16 indicates missing or incorrect information (technical issue), while CO-50 is a medical necessity denial requiring clinical documentation and physician-supported appeal.
How quickly do you respond to new denials?
Denials are identified and routed within 24-48 hours through structured workflows, ensuring rapid response and faster resolution cycles.
Do you handle RAC audit-triggered denials differently?
Yes. Audit-driven denials require compliance-focused appeals with detailed documentation and policy justification. Our team follows strict regulatory alignment to reduce risk and improve outcomes.